Albaño, Crispina I.
HRN: 08-71-24 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2025
CEFTRIAXONE 1G (VIAL)
11/23/2025
11/30/2025
IV
2g
OD
Infected AVF
Checking Initial Appropriateness
11/23/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/23/2025
11/30/2025
IV
4.5g
Q6H
Septic Shock
Checking Initial Appropriateness
11/25/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/25/2025
11/30/2025
IV
2.25gms
Q6
Renal Dosing (Sepsis)
Checking Final Appropriateness